Clapham DE. TRP channels as cellular sensors. Nature. 2003;426(6966):517–24.
Article
CAS
PubMed
Google Scholar
Oberwinkler J, Philipp SE. Trpm3. Handb Exp Pharmacol. 2014;222:427–59.
Article
CAS
PubMed
Google Scholar
Nilius B, Szallasi A. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev. 2014;66(3):676–814.
Article
PubMed
Google Scholar
Vennekens R, Menigoz A, Nilius B. TRPs in the brain. Rev Physiol Biochem Pharmacol. 2012;163:27–64.
PubMed
Google Scholar
Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011;12(3):218.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moran MM, et al. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov. 2011;10(8):601–20.
Article
CAS
PubMed
Google Scholar
Nieto-Posadas A, Jara-Oseguera A, Rosenbaum T. TRP channel gating physiology. Curr Top Med Chem. 2011;11(17):2131–50.
Article
CAS
PubMed
Google Scholar
Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007;7(9):690–702.
Article
CAS
PubMed
Google Scholar
Colsoul B, Vennekens R, Nilius B. Transient receptor potential cation channels in pancreatic beta cells. Rev Physiol Biochem Pharmacol. 2011;161:87–110.
PubMed
Google Scholar
Marshall-Gradisnik S, et al. Natural killer cells and single nucleotide polymorphisms of specific ion
channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome. Appl Clin Genet. 2016;9:39–47.
Article
PubMed
PubMed Central
Google Scholar
Marshall-Gradisnik S, et al. Single nucleotide polymorphisms and genotypes in transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic ecephalomyelitis/chronic fatigue syndrome patients. J Int Med Res. 2016 (in review).
Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953–9.
Article
CAS
PubMed
Google Scholar
Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 2007;6:6.
Article
PubMed
PubMed Central
Google Scholar
Carruthers BM, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brenu EW, et al. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights. 2013;4(3):69–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brenu EW, et al. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int Immunol. 2014;26(4):233–42.
Article
CAS
PubMed
Google Scholar
Caligiuri M, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987;139(10):3306–13.
CAS
PubMed
Google Scholar
Maher KJ, Klimas NG, Fletcher MA. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol. 2005;142(3):505–11.
CAS
PubMed
PubMed Central
Google Scholar
Ojo-Amaize EA, Conley EJ, Peter JB. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clin Infect Dis. 1994;18(Suppl 1):S157–9.
Article
PubMed
Google Scholar
Aoki T, et al. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol. 1993;69(3):253–65.
Article
CAS
PubMed
Google Scholar
Brenu EW, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012;10:88.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hardcastle SL, et al. Characterisation of cell functions and receptors in Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). BMC Immunol. 2015;16:35.
Article
PubMed
PubMed Central
Google Scholar
Huth TK, et al. Pilot study of natural killer cells in chronic fatigue syndrome/myalgic encephalomyelitis and multiple sclerosis. Scand J Immunol. 2016;83(1):44–51.
Article
CAS
PubMed
Google Scholar
Levine PH, et al. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol. 1998;88(1):96–104.
Article
CAS
PubMed
Google Scholar
Barker E, et al. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1):S136–41.
Article
PubMed
Google Scholar
Klimas NG, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28(6):1403–10.
CAS
PubMed
PubMed Central
Google Scholar
Bradley AS, Ford B, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol. 2013;172(1):73–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klimas NG, Koneru AO. Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep. 2007;9(6):482–7.
Article
CAS
PubMed
Google Scholar
Natelson BH, Haghighi MH, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol. 2002;9(4):747–52.
CAS
PubMed
PubMed Central
Google Scholar
Robertson MJ, et al. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol. 2005;141(2):326–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramos S, et al. Characterisation of B cell subsets and receptors in chronic fatigue syndrome patients. J Clin Cell Immunol. 2015;16:35.
Google Scholar
Marshall-Gradisnik S, et al. Examination of single nucleotide polymorphisms (SNPs) in transient receptor potential (TRP) ion channels in chronic fatigue syndrome patients. Immunol Immunogenet Insights. 2015;7:1–6.
Article
Google Scholar
Ramos S, et al. Characterisation of B cell subsets and receptors in chronic fatigue syndrome patients. J Clin Cell Immunol. 2015;16(1):35.
Google Scholar
Ding WX, et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 2007;282(7):4702–10.
Article
CAS
PubMed
Google Scholar
Bootman MD, et al. 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2 + release. FASEB J. 2002;16(10):1145–50.
Article
CAS
PubMed
Google Scholar
Bryceson YT, et al. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107(1):159–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rossbacher J, Shlomchik MJ. The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J Exp Med. 2003;198(4):591–602.
Article
CAS
PubMed
PubMed Central
Google Scholar
Desai BN, Clapham DE. TRP channels and mice deficient in TRP channels. Pflugers Arch. 2005;451(1):11–8.
Article
CAS
PubMed
Google Scholar
Wu LJ, Sweet TB, Clapham DE. International union of basic and clinical pharmacology. LXXVI. current progress in the mammalian TRP ion channel family. Pharmacol Rev. 2010;62(3):381–404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Badheka D, Borbiro I, Rohacs T. Transient receptor potential melastatin 3 is a phosphoinositide-dependent ion channel. J Gen Physiol. 2015;146(1):65–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Parekh AB. Mitochondrial regulation of store-operated CRAC channels. Cell Calcium. 2008;44(1):6–13.
Article
CAS
PubMed
Google Scholar
Delon J, et al. Imaging antigen recognition by naive CD4+ T cells: compulsory cytoskeletal alterations for the triggering of an intracellular calcium response. Eur J Immunol. 1998;28(2):716–29.
Article
CAS
PubMed
Google Scholar
Bhakta NR, Oh DY, Lewis RS. Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol. 2005;6(2):143–51.
Article
CAS
PubMed
Google Scholar
Lyubchenko TA, Wurth GA, Zweifach A. Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing. Immunity. 2001;15(5):847–59.
Article
CAS
PubMed
Google Scholar
Xu SZ, et al. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br J Pharmacol. 2005;145(4):405–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ouyang Q, et al. Telomere length in human natural killer cell subsets. Hematopoietic Stem Cells Vi. 2007;1106:240–52.
CAS
Google Scholar
Chan A, et al. CD56(bright) human NK cells differentiate into CD56(dim) cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179(1):89–94.
Article
CAS
PubMed
Google Scholar
Nagler A, et al. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 1989;143(10):3183–91.
CAS
PubMed
Google Scholar
Jacobs R, et al. CD56brightNK cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol. 2001;31(10):3121–6.
Article
CAS
PubMed
Google Scholar
Ellis TM, Fisher RI. Functional heterogeneity of Leu 19″bright” + and Leu 19″dim” + lymphokine-activated killer cells. J Immunol. 1989;142(8):2949–54.
CAS
PubMed
Google Scholar
Fletcher MA, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS ONE. 2010;5(5):e10817.
Article
PubMed
PubMed Central
Google Scholar
Woyach JA, Johnson AJ, Byrd JC. The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood. 2012;120(6):1175–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lewis RS. The molecular choreography of a store-operated calcium channel. Nature. 2007;446(7133):284–7.
Article
CAS
PubMed
Google Scholar
Marshall-Gradisnik S, et al. Examination of single nucleotide polymorphisms in acetylcholine receptors in chronic fatigue syndrome patients. Immunol Immunogenet Insights. 2015;7:7–20.
Article
Google Scholar